Literature DB >> 23521024

Falciform macular folds and chromosome 22q11.2: evidence in support of a locus for familial exudative vitreoretinopathy (FEVR).

Jarel K Gandhi1, Travis T Tollefson, David G Telander.   

Abstract

BACKGROUND: Familial exudative vitreoretinopathy (FEVR) is a genetic disease caused by abnormal retinal vascular development. New additional genetic loci for FEVR have recently been identified. Microduplication of 22q11.2 has been reported with a heterogeneous phenotype and microdeletion of 22q11.2 has been associated with FEVR. We describe a case of a girl with microduplication of 22q11.2 and falciform macular folds.
MATERIALS AND METHODS: The infant and first-degree relatives were examined. A dilated fundus examination was performed. Genetic screening was done by chromosomal microarray analysis and confirmed by fluorescent in situ hybridization (FISH).
RESULTS: Bilateral macular folds were found with temporal fibrosis in the proband. A chromosomal microarray revealed a 2.21 Mb microduplication of the 22q11.2 region.
CONCLUSION: This is the first report to associate microduplication of 22q11.2 with macular folds, supporting the potential for a FEVR locus on chromosome 22q11.2. We encourage full ophthalmological examination for patients with microduplication of 22q11.2 to identify ocular associations.

Entities:  

Mesh:

Year:  2013        PMID: 23521024     DOI: 10.3109/13816810.2013.779382

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  2 in total

1.  The importance of pegaptanib sodium treatment for patients with vascular active vitreoretinopathy.

Authors:  Rui Zhang; Xin Sun; Bo Niu
Journal:  Exp Ther Med       Date:  2017-10-16       Impact factor: 2.447

2.  Exposure, entropion, and bilateral corneal ulceration in a newborn as a manifestation of chromosome 22 q11.2 duplication syndrome.

Authors:  Hamid-Reza Moein; Hajirah N Saeed; Deborah S Jacobs; Yuna Rapoport; Michael K Yoon; Ankoor S Shah; Haumith Khan; Duna Raoof; Ula V Jurkunas
Journal:  Am J Ophthalmol Case Rep       Date:  2018-11-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.